Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian T Jones

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
JAMA Oncology|October 18, 2019
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
British Journal of Cancer|August 26, 2015
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerRobert N Jorissen, Michael Christie, Dmitri Mouradov, et al.
Oncotarget|May 12, 2016
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancerNirosha Suraweera, Dmitri Mouradov, Shan Li, et al.
Cancer Research|November 10, 2012
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerNicholas I Fleming, Robert N Jorissen, Dmitri Mouradov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerFiona L Day, Robert N Jorissen, Lara Lipton, et al.
Gut|February 9, 2018
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker studyJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
JAMA Oncology|October 18, 2019
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
British Journal of Cancer|August 26, 2015
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerRobert N Jorissen, Michael Christie, Dmitri Mouradov, et al.
Oncotarget|May 12, 2016
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancerNirosha Suraweera, Dmitri Mouradov, Shan Li, et al.
Cancer Research|November 10, 2012
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerNicholas I Fleming, Robert N Jorissen, Dmitri Mouradov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerFiona L Day, Robert N Jorissen, Lara Lipton, et al.
Gut|February 9, 2018
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker studyJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
Pageof 5